Roth Capital Starts Champions Oncology (CSBR) at Buy

September 20, 2019 7:59 AM EDT Send to a Friend
Roth Capital analyst Scott Henry initiates coverage on Champions Oncology (NASDAQ: CSBR) with a Buy rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login